Months after authorities flattened the curve of coronavirus infections across Europe by imposing some of the Western world’s toughest restrictions on millions of people, the virus has crept back onto the continent. Hospitals are filling up. Bars and cafes are closing down.
Sales of a groundbreaking new Alzheimer’s disease treatment from Eisai and Biogen are finally accelerating, after a sluggish launch last year. Biogen said Wednesday that…
It is the second known case of H5N1 infection in the U.S.
The first major U.S. health insurers have agreed to start paying for the popular anti-obesity drug Wegovy for certain people on Medicare with heart-related conditions.
The California-based maker of medical devices that treat cardiovascular diseases has a market value of nearly $12 billion.
A new database aims to match rare-disease patients with drugs on pharmacy shelves.
Renaming the lowest-risk prostate cancer would cut down on overly aggressive treatment, some doctors say.
Renaming the lowest-risk prostate cancer would cut down on overly aggressive treatment, some doctors say.
Medical advances are turning fatal illnesses into chronic ones, and some health problems are hitting us earlier and more widely.
Medical advances are turning fatal illnesses into chronic ones, and some health problems are hitting us earlier and more widely.
Medical advances are turning fatal illnesses into chronic ones, and some health problems are hitting us earlier and more widely.
